Model-Based Drug Development in Pulmonary Delivery: Pharmacokinetic Analysis of Novel Drug Candidates for Treatment of Pseudomonas aeruginosa Lung Infection

Antibiotic resistance is a major public health threat worldwide. In particular, about 80% of cystic fibrosis patients have chronic Pseudomonas aeruginosa (PA) lung infection resistant to many current antibiotics. We are therefore developing a novel class of antivirulence agents, quorum sensing inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Sou, Tomás, Kukavica-Ibrulj, Irena, Soukarieh, Fadi, Halliday, Nigel, Levesque, Roger C., Williams, Paul, Stocks, Michael, Cámara, Miguel, Friberg, Lena E., Bergström, Christel A.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307981/
https://www.ncbi.nlm.nih.gov/pubmed/30257195
http://dx.doi.org/10.1016/j.xphs.2018.09.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307981/
https://www.ncbi.nlm.nih.gov/pubmed/30257195
http://dx.doi.org/10.1016/j.xphs.2018.09.017

Ejemplares similares